SCHEMBL19409876

SCHEMBL19409876

O=C1C=C(Nc2ccc(F)cc2)C(=O)C=C1Nc1ccc(F)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 1/20 0.63
▸ CASP3 P42574 3/20 0.62
▸ SENP8 Q96LD8 3/20 0.62
▸ SENP7 Q9BQF6 3/20 0.62
▸ SENP6 Q9GZR1 3/20 0.62
▸ CDK4 P11802 1/20 0.50
▸ POLB P06746 3/20 0.46
▸ MAPT P10636 5/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ EGFR P00533 1/20 0.44
▸ PRKCG P05129 1/20 0.44
▸ PRKCB P05771 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ PRKCA P17252 1/20 0.44
▸ PRKCH P24723 1/20 0.44
▸ PRKCI P41743 1/20 0.44
▸ PRKCE Q02156 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16297244 0.78 CASP3 (0.77) CASP3SENP8SENP7SENP6CDK4
SCHEMBL636416 0.77 DNM1 (1.00) DNM1CASP3SENP8SENP7SENP6
SCHEMBL9650871 0.77 DNM1 (0.63) DNM1CASP3SENP8SENP7SENP6
SCHEMBL755665 0.76 MAPT (0.64) DNM1CASP3SENP8SENP7SENP6
SCHEMBL8367302 0.75 CDK4 (0.56) DNM1CASP3SENP8SENP7SENP6
SCHEMBL395770 0.74 ALDH1A1 (0.50) POLBMAPTMEN1KMT2ATDP1
SCHEMBL8548036 0.73 CDK4 (0.64) CASP3SENP8SENP7SENP6CDK4
SCHEMBL23831113 0.72 DNM1 (0.62) DNM1CASP3SENP8SENP7SENP6
SCHEMBL19409875 0.72 MAPT (0.61) DNM1CDK4POLBMAPTMEN1
SCHEMBL19409879 0.71 DNM1 (0.45) DNM1CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170283366-A1 Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives UNITED ARAB EMIRATES UNIVERSITY (AE) 2017-10-05 — — US claimed
US-20170283366-A1 Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives UNITED ARAB EMIRATES UNIVERSITY (AE) 2017-10-05 — — US disclosed
US-20170283366-A1 Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives UNITED ARAB EMIRATES UNIVERSITY (AE) 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283366-A1 Benzoquinone Derivatives For Treatment Of Cancer And Methods Of Making The Benzoquinone Derivatives BRCA1, BBOX1, KMO DNM1 1345/4885CASP3 883/4885SENP8 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback